FOXO4-DRI human trials The pursuit of longevity and age-related disease mitigation has brought senolytic agents to the forefront of scientific inquiry作者:P Krimpenfort·2017·被引用次数:32—Importantly, administration of FOXO-DRIdid not lead to any of the negativeside effectsreported for other “senolytics,” such as ABT compounds .... Among these, the peptide FOXO4-DRI has garnered significant attention for its promising ability to selectively eliminate senescent cells, often referred to as "broken aging" cells. While preclinical studies suggest a favorable safety profile, a comprehensive understanding of FOXO4-DRI side effects is crucial as research progresses towards potential human applications作者:X Han·2022·被引用次数:32—However, treatment-emergent adverse events includingupper respiratory infection, bronchitis, gastrointestinal events(nausea and diarrhoea), ....
FOXO4-DRI is a cell-permeable peptide designed to disrupt the interaction between FOXO4 and p53.Are Senolytic Agents Guilty of Overkill or Inappropriate Age ... This interaction is known to preserve senescent cells, and by interfering with it, FOXO4-DRI aims to trigger their self-destruction (apoptosis)8天前—Side effects, includingreproductive toxicity to male patients, limit its application. However, no detailed mechanisms or potential .... This mechanism is fundamental to its senolytic action, which means it has the potential to rejuvenate tissues by clearing these undesirable aging cells.
Despite the excitement surrounding its therapeutic potential, information regarding the side effects of FOXO4-DRI is primarily derived from animal studies and limited human trials. This means that while promising, the full spectrum of adverse effects in humans is not yet fully understood.
One key area of concern for any senolytic agent is the possibility of unintentional killing of healthy cells. However, early research indicates that FOXO4-DRI exhibits a high degree of selectivityModified protein promotes hair growth and fights age.... Studies have shown that FOXO4-DRI potently and selectively reduces the viability of senescent fibroblasts compared to their non-senescent counterparts. This targeted approach is a significant advantage, aiming to minimize collateral damage to healthy tissues and reduce the likelihood of systemic toxicity.
In mice, administration of FOXO4-DRI has frequently shown no overt adverse effectsFOXO4-DRI alleviates age-related testosterone secretion .... For instance, research on FOXO4-DRI in mice aimed at reversing doxorubicin-induced chemotoxicity demonstrated an increase in body weight and a reduction in liver damage markers, suggesting a lack of significant negative impacts on these vital organs. Moreover, studies involving repeated systemic delivery have resulted in reduced senescent cell numbers in the liver with minimal toxicity. Investigations into FOXO4-DRI regulating endothelial cell senescence similarly indicated that FOXO4-DRI treatment did not adversely affect liver or kidney function, with no significant differences observed in key indicators.
However, it's important to acknowledge that some potential negative side effects have been discussed in the scientific literature作者:C Zhang·2020·被引用次数:102—However, TRT has contraindications andside effectsthat cannot be ignored. TRT is not recommended for men with prostate cancer, breast cancer, severe chronic .... Some proposed concerns include:
* Disruption of Normal Tissue Function: While selectivity is a goal, any intervention that induces cell death could theoretically impact normal tissue function if not precisely controlled.Molecular modelling of the FOXO4-TP53 interaction to ...
* Immune Reactions: As a peptide, there's a potential for the immune system to react to FOXO4-DRI. This could manifest as general immunomodulation or more specific immune responses. Some researchers have noted potential immunosuppressive effects as a consideration.
* Hormonal Shifts: Given that senescent cells can influence the microenvironment, their removal could theoretically lead to subtle hormonal changes. Research on FOXO4-DRI alleviating age-related testosterone secretion suggests an interaction with hormonal pathways, though the clinical significance of this for side effects is still being explored.
* Reproductive Toxicity: One study explicitly mentions potential reproductive toxicity to male patients as a limitation for its application, highlighting a specific area for caution in this demographic.Senolytic Effects of FOXO4-DRI - Age Reversal Forum
It is instructive to compare the known and potential side effects of FOXO4-DRI with other senolytic agents.Journal Club For example, drugs like navitoclax (ABT-263) and other ABT compounds have been associated with more significant side effects, such as thrombocytopenia (low platelet count), neutropenia (low neutrophil count), and pulmonary hypertension.作者:B Bourgeois·2025·被引用次数:6—We provide a detailed characterization of the interaction of p53 withFOXO4andFOXO4-DRIwhich is the basis for development of p53 inhibitors. Importantly, a notable finding in some studies is that administration of FOXO4-DRI did not lead to any of the negative side effects reported for other senolytics like the ABT compounds. This suggests FOXO4-DRI might offer a safer alternative by avoiding these specific toxicitiesFOXO4-DRI alleviates age-related testosterone secretion ....
The method of administration can also influence potential side effects.2017年6月1日—In vivo,FOXO4-DRIreversed doxorubicin-induced chemotoxicity, including increasing body weight and reducing levels of the liver damage ... Subcutaneous injections, a common delivery method in preclinical studies, have occasionally been associated with mild inflammation at the injection site, such as redness. However, this is generally described as temporary and self-resolving. The residence half-life of FOXO4-DRI is currently unknown, which raises the question of whether there could be lasting side effects once the peptide is administered. Further research is needed to fully understand its duration of action and potential for persistent impacts.
The research into FOXO4-DRI is ongoing, and many questions remain. The limited human trial data means that side effects are not fully known.FOXO4 peptide targets myofibroblast ameliorates ... Ongoing studies are crucial to clarify the long-term safety profile. Specific populations and conditions may also have unique considerationsPeptide inhibitors targeting FOXO4-p53 interactions and .... For instance, while FOXO4-DRI aims to combat aging, individuals with certain predispositions, such as those with a history of heart attacks, strokes, poor wound healing, and kidney problems (often associated with conditions that senescent cells can exacerbate like diabetes), might theoretically experience interactions that need careful monitoring.FOXO4 DRI Side Effects and Safety Information | PEP DOSE
The ability of FOXO4-DRI to induce apoptosis of senescent cells, such as senescent renal tubular cells, has been shown to restore kidney function in preclinical models. This therapeutic benefit underscores the potential of targeted senolytic action, but it also emphasizes the need for precise control to avoid unintended consequences on healthy kidney tissue.
In conclusion, FOXO4-DRI represents a promising senolytic peptide with a potentially favorable safety profile compared to earlier generations of senolytic agents.Targeted Apoptosis of Senescent Cells Restores Tissue ... Preclinical evidence largely points towards a lack of significant systemic toxicity, with studies showing no adverse effects on major organs like the liver and kidneysModified protein promotes hair growth and fights age.... However, the possibility of unintentional killing of healthy cells, immune reactions, hormonal shifts, and potential reproductive concerns necessitates careful consideration.作者:Y Huang·2021·被引用次数:51—In this study, we hypothesized thatFOXO4-DRItreatment could remove the senescent cells in the expanded chondrocytes, thus enhancing their potential in ... As research advances, particularly through well-designed FOXO4-DRI human trials and detailed dosage studies, a clearer picture of its potential side effects will emerge, guiding its responsible development and application in the quest to combat age-related diseases.
Join the newsletter to receive news, updates, new products and freebies in your inbox.